Cardinal Health, Inc. (CAH) Balance Sheet

The balance sheet trajectory reveals a concerning pattern: asset growth, heavily driven by a near-tripling of goodwill to $13.6B, has not translated to equity value creation. Instead, the persistent and widening negative equity position indicates that the company is growing its asset base by assuming liabilities faster than it generates retained value. This suggests the recent expansion, likely acquisition-led, is increasing financial risk rather than strengthening the core balance sheet.

The debt load has grown rapidly from $5.6B in 2024Q4, outpacing asset growth and exacerbating the negative equity position. Without positive equity, traditional leverage metrics become meaningless, placing greater focus on absolute debt levels relative to cash flow. This trajectory implies that future financing needs, such as for working capital or further acquisitions, will likely require more borrowing, increasing refinancing risk and interest expense in a potentially higher-rate environment.

The asset mix reveals a significant and growing reliance on intangible assets from acquisitions. With goodwill now far exceeding the net value of tangible property, plant, and equipment ($4.0B), the balance sheet's quality is heavily dependent on the successful integration and performance of acquired businesses. Any operational missteps in the Medical segment or broader market shifts could trigger substantial write-downs, further eroding the book equity cushion.

The swing in retained earnings from negative to positive indicates improving core profitability. However, the magnitude of the negative equity position (-$2.9B) demonstrates that this improvement is currently additive rather than transformative. The equity quality is weak, as the company must generate substantial and sustained profits over multiple years just to reach a neutral equity position, limiting financial flexibility for dividends, buybacks, or weathering downturns.

Operating with a current ratio below 1.0 is not uncommon in high-volume distribution, but for Cardinal Health it reflects a chronic reliance on strong operating cash flow to meet near-term obligations. The volatility in cash balances quarter-over-quarter underscores this tightrope. The company's liquidity is highly sensitive to any slowdown in collections from pharmacy customers or disruptions in supplier payment terms, making it vulnerable to sector-specific shocks.